RVX-208: A SMALL MOLECULE THAT INCREASES APOA-I, HDL-C, AND CHOLESTEROL EFFLUX

被引：1
|
作者：
Jahagirdar, R. [1 ]
Genest, J. [2 ]
Hansen, H. C. [1 ]
Nicholls, C. D. [1 ]
Attwell, S. [1 ]
McLure, K. G. [1 ]
Wagner, G. S. [1 ]
Johansson, J. [1 ]
Wong, N. C. [1 ]
机构：
[1] Resverlogix Corp, Pharmacol, Calgary, AB, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70007-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [41] Complexation of an APOA-I mimetic peptide with phospholipid increases ABCA1-specific cholesterol efflux
    Sethi, A. A.
    Stonik, J. A.
    Demosky, S. J.
    Remaley, A. T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 13 - 13
  • [42] The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk
    Li, Li
    Cai, Gaojun
    Lu, Wei
    Li, Feng
    Yu, Lei
    Xiao, Jianqiang
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [43] Associations of HDL-C and ApoA-I with Mortality Risk in PCI Patients Across Different hsCRP Levels
    Yan, Kailun
    Li, Jiawen
    Zhu, Pei
    Tang, Xiaofang
    Li, Yulong
    Yang, Yuejin
    Gao, Runlin
    Yuan, Jinqing
    Zhao, Xueyan
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17
  • [44] The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk
    Li Li
    Gaojun Cai
    Wei Lu
    Feng Li
    Lei Yu
    Jianqiang Xiao
    BMC Cardiovascular Disorders, 21
  • [45] [HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM
    Hermans, Michel P.
    Valensi, Paul
    Ahn, Sylvie A.
    Rousseau, Michel F.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (01)
  • [46] (HDL-C/apoA-I): A Multi-Vessel Risk Marker in Women with Type 2 Diabetes
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    DIABETES, 2017, 66 : A164 - A164
  • [47] Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices
    Sorci-Thomas, Mary G.
    Bhat, Shaila
    Thomas, Michael J.
    CLINICAL LIPIDOLOGY, 2009, 4 (01) : 113 - 124
  • [48] DIFFERENT EFFECTS OF SUBCLASSES OF HDL, CONTAINING APOA-I BUT NOT APOA-II (LPA-I) ON CHOLESTEROL ESTERIFICATION IN PLASMA AND NET CHOLESTEROL EFFLUX FROM FOAM CELLS
    OHTA, T
    SAKU, K
    TAKATA, K
    NAKAMURA, R
    IKEDA, Y
    MATSUDA, I
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (07) : 956 - 962
  • [49] HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
    Ruth Blanco-Rojo
    Pablo Perez-Martinez
    Javier Lopez-Moreno
    Javier Martinez-Botas
    Javier Delgado-Lista
    Ben van-Ommen
    Elena Yubero-Serrano
    Antonio Camargo
    Jose M. Ordovas
    Francisco Perez-Jimenez
    Diego Gomez-Coronado
    Jose Lopez-Miranda
    Scientific Reports, 7
  • [50] HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
    Blanco-Rojo, Ruth
    Perez-Martinez, Pablo
    Lopez-Moreno, Javier
    Martinez-Botas, Javier
    Delgado-Lista, Javier
    Van-Ommen, Ben
    Yubero-Serrano, Elena
    Camargo, Antonio
    Ordovas, Jose M.
    Perez-Jimenez, Francisco
    Gomez-Coronado, Diego
    Lopez-Miranda, Jose
    SCIENTIFIC REPORTS, 2017, 7
12345